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Introduction. —   In a model-theoretic context of long-range correlations in DNA, Roche 
et al. [5]  have studied Fibonacci polyGC quasiperiodic sequences based on the inflation rule 
G→GC and C→G, which gives successively G, GC, GCG, GCGGC, GCGGCGCG, . . . for 
sequences of length 1, 2, 3, 5, 8, . . . respectively.  It appears that such Fibonacci sequences can 
be used as prototypes for strongly correlated DNA segments as long as ~160 nm (i.e., ~450 bp).   
More than fifty years ago, Weyl [9] showed that the symmetry in biological phenotypes 
can be quantified by basic group theory, as shown for example in Fig. 1.  That Fibonacci and 
other symmetries may exist in the sequences of DNA’s, RNA’s and certain proteins is suggested 
by the recent findings of motif pattern sequences—— the so-called seqlets  [3, 4] that occur 
repeatedly in proteins.  Typically featuring about 10 amino acid residue positions that are fixed 
to within conservative substitutions but usually separated by a number of prescribed gaps with 
arbitrary residue content, the existence of protein-fragment seqlets poses an intriguing question:  
Do certain seqlets have a sequence with a symmetry precisely quantifiable by group theory?  
This question is answered affirmatively in the present communication.  We have found a precise 
modular Fibonacci sequence in a continuous gap-free 10-residue seqlet with either 3 or 4 
conservative amino acid substitutions.  Unambiguous statistical significance is attached to this 
modular Fibonacci seqlet, for it occurs nine times in the SWISS-Prot/TrEMBL database [1,2] of 
natural proteins.  As in many cases of phenotypic symmetry [9], cyclic group theory here again 
provides the medium for the analysis.  
 
Nucleotide and codon representative cyclic groups. —   We start with a purely physical 
 (cyclic group of order 4) representation for the nucleotides.  As shown in Table 1, the 
number of oxygen and nitrogen atoms  and  along with the molecular ring numbers r 
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engender the complex number  z = (  (i)nO –1)nN –r  for each nucleotide.  Constituting a 
representation of , the four complex numbers have the form  z = exp(iC4 nπ / 2) where [6,7]  
n(U) = 0,  n(C) = 1,  n(A) = 2  and n(G) = 3. Note that under the complementarity transpositions 
U A,  C G,  we have z→ –z for all z. ↔ ↔
 Next, we make the biologically appropriate foliation of the  cyclic group for the 
nucleotides into a  (cyclic group of order 64) representation for the codons.  Let (N
C4
C64 5' – N 
N+)   denote a generic codon with the successive triplet of  nucleotides N3' – , N , N+.  Then the 
codon’s  representative is defined by   C64
 
 Z = ( z – )
1/4z ( z+ )1/16 = exp (iNπ / 32)  (1) 
 
in which z –, z,  are the  representatives of the respective nucleotides and the principal-
branch roots are taken by the fractional exponents on 
z+ C4
z – and z+ in the middle member of (1).  
The codon number N introduced by implicit definition in the final member of (1) is therefore 
given by [6,7] 
 
 N = 4 n – + 16n +  (2) n +
 
Thus, for example, with (N5' – N N+)  = AUG for Methionine, we have N = 4n(A) + 16n(U) + 
n(G) = 11.  Observe that N runs from 0 to 63 along with the codons in the natural progression of 
the universal genetic code (see Table 2).  Finally, the code itself assigns one of the 20 amino 
acids or the “stop” signal to each codon, and thus concomitantly to its codon number N.  Hence, 
a value for N implies an amino acid or the “stop” signal (the latter, in the cases N = 34, 35 or 50).  
Moreover, a sequence of Z’s of the form (1), or equivalently a sequence of N values, implies a 
specific polypeptide which may or may not be a continuous gap-free seqlet. 
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 Modular Fibonacci sequences. —   Now let Zk–1, Zk , Zk+1  denote the  
representatives of three successive codons in an mRNA.  Suppose that through the formation 
mechanism of the mRNA the representative 
C64
Zk+1 depends on its two predecessors Zk , Zk–1 
in a symmetrical-function manner over a range of integer k values, thereby representing a group-
theoretic direct-product surjection of the form (k) x (k–1) → (k +1).  The only 
uniformly consistent way that this can happen is for the  representatives to satisfy  
C64 C64 C64
C64 Zk+1 = 
Zk Zk–1  for all k in the range, a relation equivalent to the modular Fibonacci sequence 
condition 
  Nk+1 = ( Nk  + Nk–1) (mod 64) (3) 
 
Here “mod 64” instructs one to “subtract 64 from the sum if it is greater than 63”, for Z in (1) is 
unchanged by N → (N – 64) and N ranges from 0 to 63 by definition in (2).   
 A sequence of Nk ’s (to which there is an associated polypeptide) follows from (3) if one 
prescribes  N1, N2  and the range of  k.  As a prime example, consider the biological sequence 
that features N1 = 11 for M (see Table 2), the “start” signal for a protein, and  N2 = 33, which is 
M’s partner under nucleotide complementarity:  N1 = 11 ⇔ AUG ↔ UAC   ⇔ N2 = 33.  
Then (3) employed recursively produces the sequence 
   11   33   44   13   57   6   63   5   4   9   13   22   35 
Note that we have terminated the sequence at k = 13, because N13 = 35 signals “stop”.  By using 
Table 2 the sequence translates into the polypeptide  
 M Y D V S L G L L I V P (stop) 
which finally yields the modular Fibonacci seqlet 
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 Y  D  V  S  L  G  L  L  I  V (4) 
In (4) we have deleted the M (interpreted as a “start” signal) and the P (for terminal deletion 
symmetry).  The standard equivalence classes for amino acid conservative substitutions are {F, 
Y}, {L, I, M, V}, {S, T}, {P}, {A, G}, {H}, {Q, N}, {K. R}, {D. E}, {C}, [W}, as permitted 
by the SWISS-Prot/TrEMBL BLAST program [1,2].  With (4) as the query, the SWISS-
Prot/TrEMBL database (containing 137,811 non-redundant sequences with 50,431,180 total 
letters when accessed) identified the following nine protein segments as biological equivalents to 
(4): 
 >gi 3122441 sp 021077 NU1M_MYXGL NADH-ubiquinone oxidoreductase chain 1 
  Length = 318 Identities = 7/10 (70%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV  10 
  Y+V+LGL+IV 
Subject: 144 YEVTLGLMIV 153 
 
 >gi 266658 sp P29920 NQO8_PARDE NADH-quinone oxidoreductase chain 8 
(NADH dehydrogenase:  NDH-1, chain 8) 
  Length = 345 Identities = 7/10 (70%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV  10 
   Y+VSLGL+I+ 
Subject: 157 YEVSLGLIII 166  
 
 >gi 1171804 sp P42032 NUOH_RHOCA NADH-quinone oxidoreductase chain H 
(NADH dehydrogenase:  NDH-1, chain H) 
  Length = 345 Identities = 7/10 (70%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV 10 
   Y+VS+GL+IV 
Subject: 157 YEVSMGLIIV 166  
 
 >gi 6647674 sp Q9ZCF7 NUOH_RICPR NADH-quinone oxidoreductase chain H 
(NADH dehydrogenase:  NDH-1, chain H) 
  Length = 339 Identities = 6/10 (60%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV 10 
   Y+VS+GL+I+ 
Subject: 157 YEVSMGLVII 166  
 
 >gi 1352538 sp P48899 NUIM_CYACA NADH- ubiquinone oxidoreductase chain 1  
  Length = 344 Identities = 6/10 (60%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV 10 
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   Y+VS+GL+I+ 
Subject: 165 YEVSIGLIII 174 
 
 >gi 14194971 sp 079546 NUIM_DINSE NADH- ubiquinone oxidoreductase chain 1  
  Length = 321 Identities = 6/10 (60%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV 10 
   Y+V+LGL+I+ 
Subject: 148 YEVTLGLIII 157  
 
 >gi 2499233 sp Q96182 NUIM_POLOR NADH- ubiquinone oxidoreductase chain 1  
  Length = 319 Identities = 6/10 (60%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV  10 
   Y+V+LGL+I+ 
Subject: 146 YEVTLGLIII 155  
 
 >gi 462756 sp P26845 NUIM_MARPO NADH-ubiquinone oxidoreductase chain 1  
  Length = 328 Identities = 6/10 (60%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV 10 
   Y+VS+GLL++ 
Subject: 150 YEVSIGLLLI 159  
 
 >gi 3122451 sp Q37556 NUIM_METSE NADH-ubiquinone oxidoreductase chain 1  
  Length = 334 Identities = 6/10 (60%), Positives = 10/10 (100%) 
Query: 1 YDVSLGLLIV 10 
   Y+VS+GL+I+ 
Subject: 157 YEVSIGLIII 166  
 
 Statistical significance. —   Observe that (3) prescribes the 9 amino acids that follow Y 
in (4), with N1 = 11 and N2 = 33.  For an incidentally random sequence, the probability of a 
single appearance of a biological equivalent of (4) with Y in the first position and j conservative 
substitutes in the subsequent nine positions is given approximately by  φ j = (9!/(9–j)! j!) 
(.05  (.11  (5.04 10)10–j )j × 7), in which (.05) is the average probability for any one of the 20 
amino acids, (.11) is the average probability for  an amino acid or one of its biological 
equivalents, and (5.04 10× 7) is the approximate number of total letters, i.e., chances for a hit in 
the database; for j = 3 and 4 we therefore have φ3 = 4.40 ×10–3 and  φ4 =1.45 .  Thus, ×10–2
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even with suitable latitude given to evolutionary correlations between the SWISS-Prot/TrEMBL 
protein fragments cited above, it follows that the incidental random-sequence composite 
probability for three j = 3 and six j = 4 conformances is small enough to preclude an incidental 
origin for the accord with virtual certainty.  Therefore, the modular Fibonacci seqlet shown in (4) 
can be deemed to be genuinely biophysical. 
 
 A possible dynamical origin for modular Fibonacci seqlets. —   In conclusion, it should 
be emphasized that the nucleotide group , the codon group , and hence a modular 
Fibonacci sequence in proteins have a precise biophysical underpinning in terms of nucleotide 
and codon aerobic-atom content and molecular  ring structure, as expressed by and  n , n  and 
r.  The z’s of  and the Z’s of  may perhaps also have a quantum physics origin as 
wavefunction prefactors that result from the nucleotide and codon production reactions.  
Consonant with their aerobic-atom content and molecular ring structure, the z’s may have 
originated dynamically as relative prefactors in the nucleotide groundstate wavefunctions; if so, 
the phase angles in the z,  nπ
C4 C64
Ο N
C4 C64
/ 2,  may be interpreted as residual Berry phase angles [8] from the 
nucleotide production process.  Furthermore, if the Zk ’s are residual Berry phase factors from 
the codon production process, then the relation  Zk+1 = Zk Zk–1  and its equivalent (3) 
minimize an energy of the form –ε  Re( Zk+1*
k
∑ Zk Zk–1), where the constant ε  is the 
magnitude of an intercodon binding energy increment in the mRNA groundstate.  Irrespective of 
the underlying mechanism, however, the biophysical genuineness of the modular Fibonacci 
sequence is clearly indicated statistically. 
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Figure 1   
 Half-shell of a pearly Nautilus in which the edge of the coil is a near-perfect logarithmic 
spiral [5], a curve such that the rates of rotation and dilatation are proportional [hence yielding 
].  The self-similar air chambers increase in diameter according to a fractionally-
muted Fibonacci relation [viz., = (const) (f
  θ ∝ ln (r / ro )
d k k )
1 / 8  for the kth chamber, where fk  = 1, 2, 3, 5, 8, 
13, 21, . . .  is the primary Fibonacci series]. 
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Table 1   
The nucleotide  representatives C4 z = ( i)nO (–1)nN –r .  Here nΟ , n , and r are the 
number of oxygen atoms, nitrogen atoms, and rings in the nucleotide molecule, the 
quantities that determine its z value. 
N
________________________________________________________________ 
  n   r z nNΟ
________________________________________________________________ 
  U, uracil 2 2 1 1 
   
 pyrimidines T, thymine 2 2 1 1 
  
  C, cytosine 1 3 1 i 
 _________________  
 A, adenine 0 5 2 –1 
 purines 
  G, guanine 1 5 2 –i 
________________________________________________________________ 
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Table 2 
The universal genetic code annotated with codon numbers.  The code associates 61 mRNA 
codons—ordered triplets of the nucleotides U, C, A, G—with the 20 lifeform amino acids.  In 
particular, AUG for M also serves as a “start” signal for a protein, while UAA, UAG and UGA 
signal “stop” by not being associated with any amino acid.  The codon number N [given by Eq. 
(2)] appears to the left of each respective codon, and the associated amino acid along with its 
letter symbol  appears to the right of its codon correspondents. 
___________________________________________________________________ 
 
 0 UUU Phenylalanine 16 UCU   32 UAU Tyrosine 48 UGU Cysteine 
 
 1 UUC F  17 UCC Serine 33 UAC Y 49 UGC  C 
______________       ______________ ______________ 
 2  UUA    18 UCA  S 34 UAA (stop) 50 UGA (stop) 
             ______________ 
 3 UUG    19 UCG  35 UAG (stop) 51 UGG Tryptophan W 
     ______________ ______________ ______________ 
 4 CUU Leucine  20 CCU  36 CAU Histidine 52 CGU  
            
 5 CUC  L  21 CCC Proline 37 CAC H 53 CGC Arginine 
         ______________ 
 6 CUA    22 CCA  P  38 CAA Glutamine 54 CGA  R 
 
 7 CUG    23 CCG  39 CAG Q 55 CGG 
______________   ______________ ______________ ______________ 
 8 AUU    24 ACU  40 AAU Asparagine 56 AGU Serine 
 
 9 AUC Isoleucine  25 ACC Threonine 41 AAC N 57 AGC  S 
         ______________ ______________ 
10 AUA  I  26 ACA  T 42 AAA Lysine 58 AGA Arginine 
____________  
11 AUG Methionine M 27 ACG   43 AAG K 59 AGG  R 
____________(start)  ____________ ____________  ____________ 
12 GUU    28 GCU    44 GAU Aspartic acid 60 GGU  
 
13 GUC Valine  29 GCC Alanine 45 GAC  D 61 GGC Glycine 
         ____________ 
14 GUA  V 30 GCA  A 46 GAA Glutamic acid 62 GGA  G 
 
15 GUG    31 GCG   47 GAG E 63 GGG   
 
___________________________________________________________________ 
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